Favorable response to pembrolizumab in granulocyte colony‐stimulating factor‐producing upper urinary tract urothelial carcinoma

Favorable response to pembrolizumab in granulocyte colony‐stimulating factor‐producing upper urinary tract urothelial carcinoma

Introduction Granulocyte colony‐stimulating factor‐producing upper urinary tract urothelial carcinoma is rare, with a poor prognosis. Advanced urothelial carcinoma is currently treated with immune checkpoint inhibitors, whose efficacy for granulocyte colony‐stimulating factor‐producing upper urinary...

Full description

Bibliographic Details
Main Authors: Hiroki Takeda, Ryuji Matsumoto, Emi Takakuwa, Kanta Hori, Takuya Moriguchi, Shuhei Yamada, Hiroshi Kikuchi, Takahiro Osawa, Takashige Abe, Nobuo Shinohara
Format: Article
Language:English
Published: Wiley 2022-03-01
Series:IJU Case Reports
Subjects:
granulocyte colony‐stimulating factor
pembrolizumab
upper urinary tract urothelial carcinoma
Online Access:https://doi.org/10.1002/iju5.12406

Internet

https://doi.org/10.1002/iju5.12406

Similar Items